I'm glad to hear the proof-of-concept trials with four leading hospital trusts in England are going well. This announcement was back in March this year (22/3/22)
One of the contracts are up for review in September....
And this is today's announcement...
Revenue for FY23 could exceed $23M if organic growth accelerates. Remember only 9 months of Potential (x) revenue is included in FY22. Revenue from Ampath ($2M approx) will be included in FY23.
I'm glad to hear the proof-of-concept trials with four leading...
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BMT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.03M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.5¢ | $60.38K | 268.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 137912 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 35244 | 3 |
View Market Depth
| Last trade - 12.03pm 26/07/2024 (20 minute delay) ? |
| BMT (ASX) Chart |